A role for the complement system in seizure induced neuronal and dendritic injury
补体系统在癫痫引起的神经元和树突损伤中的作用
基本信息
- 批准号:9898484
- 负责人:
- 金额:$ 33.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAntiepileptic AgentsApoptosisAttenuatedBiochemicalBiologicalBrainCognitiveCognitive deficitsComplementComplement 1qComplement 3aComplement 3bComplement 5aComplement ActivationComplement InactivatorsDLG4 geneDendritesDendritic SpinesDevelopmentEatingElectroencephalogramElectrophysiology (science)EpilepsyExcisionExperimental ModelsFDA approvedGenerationsGlutamatesHippocampus (Brain)HistologicHistopathologyHumanImmuneImmunologicsImpairmentIndividualInflammatoryInjuryIntractable EpilepsyKnockout MiceLinkMeasuresMediatingMemoryMemory LossMemory impairmentMessenger RNAMicrogliaModelingModificationMusNeurodegenerative DisordersNeuronsPathologicPhagocytesPhagocytosisPharmaceutical PreparationsPhysiologicalPredispositionProteinsResearchRiskRoleSeizuresSignal TransductionStatus EpilepticusStructureSynapsesSystemTemporal Lobe EpilepsyTestingTherapeuticTimeVirus Diseasesage relatedbehavior testcognitive disabilitycognitive functioncomorbiditycomplement systemexcitotoxicityimmune activationinflammatory markermouse modelneuroinflammationneuron lossneuropathologyreceptorrelating to nervous systemresponsetherapeutic target
项目摘要
Project Summary
Epilepsy is a seizure disorder that is often comorbid with cognitive disabilities. Prolonged-continuous seizures
(status epilepticus; SE) increase the risk for the development of temporal lobe epilepsy (TLE) by remodeling
synaptic connectivity in vulnerable neuronal networks such as those of the hippocampus. Extensive evidence
supports that SE-induced hippocampal synaptodendritic remodeling orchestrated through glutamate
excitotoxicity, apoptosis, and aberrant activation from a number of intracellular signaling cascades is linked to
the neuronal hyperexcitability that often results in seizures. Despite these findings, the mechanisms that
directly impact neural hyperexcitability remain elusive. A prominent hallmark in the histopathology of SE and
epilepsy is activation of microglia, which mediate neuroinflammatory and phagocytic responses. It is well
known that microglia-mediated neuroinflammatory mechanisms contribute to seizures; however, a gap remains
on the potential role of their phagocytic responses. During and after SE microglia make multiple physical
contacts with cortical and hippocampal dendrites, a phenomenon that we recently found in human refractory
epilepsy. These contacts may result in the phagocytosis of dendritic structures and thereby modification of
neuronal connectivity. Recent studies discovered that C1q and C3 proteins from the immune complement
system send “eat-me” signals that guide microglia to phagocytose extranumerary synapses in the normal
developing brain. In addition, C1q and C3 are associated with the pathological removal of hippocampal
synaptic structures in models of neurodegenerative disorders. We and others found increases in C1q-C3
mRNA and protein levels in intractable human epilepsy and after SE in experimental models. Therefore, we
hypothesized that seizure-induced activation of the immune complement system contributes to hippocampal
synaptodendritic modifications that promote neuronal/network hyperexcitability, seizures, and memory deficits.
We will pursue the following Aims, Aim1: To characterize complement activation and associated responses in
a mouse model of SE and TLE; Aim2: To determine the contribution of SE-induced C3 activation to neuronal
and synaptodendritic changes in the hippocampus in a mouse model of TLE; Aim3: To determine the
contribution of SE-induced C3 activation to seizures and hippocampal-dependent memory deficits in a mouse
model of TLE. This study will provide a strong framework for understanding the phagocytic role of the innate
immune complement system and microglia in the SE-induced generation of epileptic circuits. Our scientific
discoveries are likely to provide evidence for the potential therapeutic value of directly modulating the
complement cascade to attenuate seizures and cognitive comorbidities in epilepsy. Importantly, because FDA-
approved complement inhibitors are currently being used for immunological illnesses in humans, our study
may provide evidence to fast track the repurposing of these drugs for their use in epilepsy.
1
项目概要
癫痫是一种癫痫症,通常伴有认知障碍。
(癫痫持续状态;SE)通过重塑增加发生颞叶癫痫 (TLE) 的风险
脆弱神经网络(例如海马体)中的突触连接。
支持 SE 诱导的海马突触树突重塑是通过谷氨酸协调的
兴奋性毒性、细胞凋亡和许多细胞内信号级联的异常激活与
尽管有这些发现,但经常导致癫痫发作的神经过度兴奋的机制。
SE 的组织病理学的一个显着特征仍然是难以直接影响神经过度兴奋。
癫痫是小胶质细胞的激活,它介导神经炎症和吞噬反应。
已知小胶质细胞介导的神经炎症机制会导致癫痫发作;然而,仍然存在差距;
SE 小胶质细胞在进行多种物理过程期间和之后其吞噬反应的潜在作用。
与皮质和海马树突的接触,这是我们最近在人类难治性中发现的一种现象
这些接触可能导致树突结构的吞噬作用,从而改变
最近的研究发现,C1q 和 C3 蛋白来自免疫补体。
系统发送“吃我”信号,引导小胶质细胞吞噬正常情况下的额外突触
此外,C1q 和 C3 与海马的病理性切除有关。
我们和其他人发现 C1q-C3 的增加。
因此,我们在实验模型中研究了难治性人类癫痫和 SE 后的 mRNA 和蛋白质水平。
认为癫痫发作诱导的免疫补体系统激活有助于海马
促进神经元/网络过度兴奋、癫痫发作和记忆缺陷的突触树突修饰。
我们将追求以下目标,目标 1:表征补体激活和相关反应
SE 和 TLE 小鼠模型;目的2:确定 SE 诱导的 C3 激活对神经元的贡献
TLE 小鼠模型中海马的突触树突变化;
SE 诱导的 C3 激活对小鼠癫痫发作和海马依赖性记忆缺陷的影响
这项研究将为理解先天吞噬细胞的作用提供一个强有力的框架。
SE 诱导的癫痫回路生成中的免疫补体系统和小胶质细胞。
这些发现可能为直接调节的潜在治疗价值提供证据
补体级联反应可减轻癫痫发作和认知合并症,因为 FDA-
我们的研究表明,已批准的补体抑制剂目前正用于治疗人类免疫性疾病
可能会提供证据来快速追踪这些药物用于治疗癫痫的用途。
1
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amy L. Brewster其他文献
Human iPSC-derived microglia sense and dampen hyperexcitability of cortical neurons carrying the epilepsy-associated SCN2A-L1342P mutation
人类 iPSC 衍生的小胶质细胞感知并抑制携带癫痫相关 SCN2A-L1342P 突变的皮质神经元的过度兴奋
- DOI:
10.1101/2023.10.26.563426 - 发表时间:
2023-10-31 - 期刊:
- 影响因子:0
- 作者:
Zhefu Que;Maria I. Olivero;Ian Chen;Jingliang Zhang;Kyle Wettschurack;Jiaxiang Wu;Tiange Xiao;C. M. Otterbacher;Muhan Wang;Hope Harlow;Ningren Cui;Xiaoling Chen;Brody Deming;Manasi Halurkar;Yuanrui Zhao;Jean;Ranjie Xu;Amy L. Brewster;Long;Chongli Yuan;W. Skarnes;Yang Yang - 通讯作者:
Yang Yang
Exploring Dendritic and Spine Structural Profiles in Epilepsy: Insights From Human Studies and Experimental Animal Models
探索癫痫的树突状和脊柱结构特征:来自人类研究和实验动物模型的见解
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:3.6
- 作者:
Shikha Kumari;Amy L. Brewster - 通讯作者:
Amy L. Brewster
Amy L. Brewster的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amy L. Brewster', 18)}}的其他基金
A role for the complement system in seizure induced neuronal and dendritic injury
补体系统在癫痫引起的神经元和树突损伤中的作用
- 批准号:
10618036 - 财政年份:2022
- 资助金额:
$ 33.39万 - 项目类别:
A role for the complement system in seizure induced neuronal and dendritic injury
补体系统在癫痫引起的神经元和树突损伤中的作用
- 批准号:
9448841 - 财政年份:2019
- 资助金额:
$ 33.39万 - 项目类别:
相似国自然基金
选择性靶向BK(α+β4)离子通道的抗癫痫多肽药charybdotoxin突变体Q18F设计与分子机制研究
- 批准号:22177127
- 批准年份:2021
- 资助金额:63 万元
- 项目类别:面上项目
GRIN2A基因突变导致特发性全面性癫痫的机制及对抗癫痫药物反应性影响的研究
- 批准号:81871015
- 批准年份:2018
- 资助金额:56.0 万元
- 项目类别:面上项目
药物转运体基因ABCB1启动子核苷酸多态性结合DNA甲基化对难治性癫痫的影响及其分子机制研究
- 批准号:81703613
- 批准年份:2017
- 资助金额:20.1 万元
- 项目类别:青年科学基金项目
CGREF1基因调控MAPK信号通路在芳香族抗癫痫药诱发的严重皮肤不良反应中的作用及分子机制研究
- 批准号:81602754
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
广谱抗癫痫药丙戊酸诱导裂殖酵母蛋白糖基化缺陷的机制研究
- 批准号:31560325
- 批准年份:2015
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
相似海外基金
A role for the complement system in seizure induced neuronal and dendritic injury
补体系统在癫痫引起的神经元和树突损伤中的作用
- 批准号:
10618036 - 财政年份:2022
- 资助金额:
$ 33.39万 - 项目类别:
A role for the complement system in seizure induced neuronal and dendritic injury
补体系统在癫痫引起的神经元和树突损伤中的作用
- 批准号:
9448841 - 财政年份:2019
- 资助金额:
$ 33.39万 - 项目类别:
Structural and functional sequelae of neonatal anticonvulsant exposure: drug-seizure interactions
新生儿抗惊厥药物暴露的结构和功能后遗症:药物与癫痫发作的相互作用
- 批准号:
10454335 - 财政年份:2018
- 资助金额:
$ 33.39万 - 项目类别:
Structural and functional sequelae of neonatal anticonvulsant exposure: drug-seizure interactions
新生儿抗惊厥药物暴露的结构和功能后遗症:药物与癫痫发作的相互作用
- 批准号:
10453914 - 财政年份:2018
- 资助金额:
$ 33.39万 - 项目类别:
Structural and functional sequelae of neonatal anticonvulsant exposure: drug-seizure interactions
新生儿抗惊厥药物暴露的结构和功能后遗症:药物与癫痫发作的相互作用
- 批准号:
10654181 - 财政年份:2018
- 资助金额:
$ 33.39万 - 项目类别: